Semaglutide is a long acting synthetic GLP-1 receptor agonist with a half-life of approximately 7 days, achieved through fatty acid chain conjugation enabling albumin binding and protection against DPP-4 enzymatic degradation. F40 Biotech’s 4mg adjustable dose pen delivers Semaglutide at the mid range concentration point in CSD’s Semaglutide pen lineup. Above the 2mg adjustable pen entry point and below the 9.6mg fixed dose prefilled pen, with the adjustable dose mechanism allowing researchers to dial precise incremental doses without reconstitution preparation across the pen’s usage period. F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. Researchers comparing manufacturer options within CSD’s Semaglutide 4mg adjustable pen range will find the base compound pharmacology, GLP-1 receptor binding characteristics, and 7 day half-life profile consistent across both the F40 Biotech and generic brand listings. Manufacturer preference and availability representing the primary differentiating variables between the two. CSD’s complete Semaglutide range spans the 2mg adjustable single pen, the 4mg adjustable pen in both manufacturer variants, the 9.6mg fixed dose prefilled pen, and the 10mg lyophilized vial, covering every Semaglutide format and concentration requirement from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior. Store at 2–8°C away from direct light. Do not freeze. Keep upright. Intended for research purposes only. Commonly researched alongside dual and triple incretin agonist compounds in comparative GLP-1 receptor pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.